相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High mobility group box 1 orchestrates tissue regeneration via CXCR4
Mario Tirone et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
CXCL4 and CXCL4L1 in cancer
Pieter Ruytinx et al.
CYTOKINE (2018)
Cancer-related circulating and tumor-associated neutrophils - subtypes, sources and function
Merav E. Shaul et al.
FEBS JOURNAL (2018)
Dendritic Cell-Based Cancer Vaccines
Patricia M. Santos et al.
JOURNAL OF IMMUNOLOGY (2018)
Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert
Geoffrey Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
COOH-terminal SAA1 peptides fail to induce chemokines but synergize with CXCL8 and CCL3 to recruit leukocytes via FPR2
Mieke De Buck et al.
BLOOD (2018)
High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
Marco E. Bianchi et al.
IMMUNOLOGICAL REVIEWS (2017)
Human regulatory B cells in health and disease: therapeutic potential
Claudia Mauri et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation
Philipp von Hundelshausen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
Larissa Kistner et al.
ONCOTARGET (2017)
Leukocyte trafficking in tumor microenvironment
Annalisa Del Prete et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer
Chunyan Gu-Trantien et al.
JCI INSIGHT (2017)
Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking
Valentina Cecchinato et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
F. Guo et al.
ONCOGENE (2016)
Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling
Danfeng Sun et al.
ONCOIMMUNOLOGY (2016)
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
Holger Bronger et al.
BRITISH JOURNAL OF CANCER (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Modulation of Chemokine Responses: Synergy and Cooperativity
Amanda E. I. Proudfoot et al.
FRONTIERS IN IMMUNOLOGY (2016)
Potential of PEGylated Toll-Like Receptor 7 Ligands for Controlling Inflammation and Functional Changes in Mouse Models of Asthma and Silicosis
Tatiana Paula Teixeira Ferreira et al.
FRONTIERS IN IMMUNOLOGY (2016)
Cancer cell-derived IL-1 induces CCL22 and the recruitment of regulatory T cells
Gabriela Maria Wiedemann et al.
ONCOIMMUNOLOGY (2016)
B cell regulation of the anti-tumor response and role in carcinogenesis
Marc Schwartz et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
Takanori Kitamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Dongjun Peng et al.
NATURE (2015)
Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity
Claire Germain et al.
FRONTIERS IN IMMUNOLOGY (2015)
DAMPs from cell death to new life
Emilie Venereau et al.
FRONTIERS IN IMMUNOLOGY (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
Ilona Kryczek et al.
IMMUNITY (2014)
CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model
Steve Oghumu et al.
IMMUNOLOGY (2014)
New nomenclature for atypical chemokine receptors
Francoise Bachelerie et al.
NATURE IMMUNOLOGY (2014)
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Francoise Bachelerie et al.
PHARMACOLOGICAL REVIEWS (2014)
Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells
Anna Fialova et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
HMGB1 and leukocyte migration during trauma and sterile inflammation
Emilie Venereau et al.
MOLECULAR IMMUNOLOGY (2013)
CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
Nassima Redjimi et al.
CANCER RESEARCH (2012)
Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response
Mieke Gouwy et al.
IMMUNOLOGY LETTERS (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
Eva Schlecker et al.
JOURNAL OF IMMUNOLOGY (2012)
Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
Ende Zhao et al.
ONCOIMMUNOLOGY (2012)
Targeting natural killer cells and natural killer T cells in cancer
Eric Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Maximal T Cell-Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
Alicia Gonzalez-Martin et al.
CANCER RESEARCH (2011)
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
Marie Tosolini et al.
CANCER RESEARCH (2011)
Chemokines in cancer related inflammation
Paola Allavena et al.
EXPERIMENTAL CELL RESEARCH (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells
Daniel Venetz et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Ilona Kryczek et al.
BLOOD (2009)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells
Purevdorj B. Olkhanud et al.
CANCER RESEARCH (2009)
Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes
Katrin Kuscher et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Natalia Martin-Orozco et al.
IMMUNITY (2009)
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Thomas Duhen et al.
NATURE IMMUNOLOGY (2009)
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice
Rory R. Koenen et al.
NATURE MEDICINE (2009)
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
Katy Milne et al.
PLOS ONE (2009)
Trophic macrophages in development and disease
Jeffrey W. Pollard
NATURE REVIEWS IMMUNOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
CXCL13 is highly produced by Sezary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines
Maria Cristina Picchio et al.
CANCER RESEARCH (2008)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years
Bettina S. Nedergaard et al.
GYNECOLOGIC ONCOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis
Moritz N. Wente et al.
CANCER LETTERS (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Inflammatory chemokines in cancer growth and progression
BJ Rollins
EUROPEAN JOURNAL OF CANCER (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Synergy in cytokine and chemokine networks amplifies the inflammatory response
M Gouwy et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2005)
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma
S Wei et al.
CANCER RESEARCH (2005)
A rich chemokine environment strongly enhances leukocyte migration and activities
S Paoletti et al.
BLOOD (2005)
CCL22-induced responses are synergy inducing chemokines involvement of first powerfully enhanced by via CCR4:: evidence for the β-strand of chemokine
S Sebastiani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors
K Gijsbers et al.
EXPERIMENTAL CELL RESEARCH (2005)
Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level
IV Nesmelova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
P von Hundelshausen et al.
BLOOD (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration
M Gouwy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12
B Vanbervliet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The unique property of the CC chemokine regakine-1 to synergize with other plasma-derived inflammatory mediators in neutrophil chemotaxis does not reside in its NH2-terminal structure
M Gouwy et al.
MOLECULAR PHARMACOLOGY (2002)
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
WP Zou et al.
NATURE MEDICINE (2001)
Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1
S Struyf et al.
BLOOD (2001)
Regulator of G protein signaling 1 (RGS1) markedly impairs Giα signaling responses of B lymphocytes
C Moratz et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
